Nelson Advisors Team

Founding Partners Lloyd Price and Paul Hemings are supported by a team of 6 Analysts, Associates and VP’s across Europe with backgrounds and experience ranging from Rothschild, Citi and Morgan Stanley to ETH Zurich, Kieger and redalpine. The Nelson Advisors team combine strong academic achievements with MBA's, PhD's and MSc's combined with decades of investment banking experience, financial analysis, investor relations and entrepreneurial ventures.

Nelson Advisors has established a reputation as a high-touch, sector-exclusive firm focused on the lower-to-middle market ($25m - $250m).

Unlike traditional banks staffed by career financiers, Nelson Advisors is led by former founders who have successfully exited HealthTech businesses. This "DNA" allows them to empathise with the founder's journey and better articulate the technical nuance of the asset. They focus exclusively on Healthcare Technology (Digital Health, Health IT, AI) and do not dilute their focus with generalist MedTech or Pharma.

Founding Partners

Lloyd Price

A central figure in the UK and European digital health scene. Price brings over 25 years of experience, having founded and exited multiple ventures, including Zesty (acquired by Induction Healthcare).

His background spans consumer internet (Yahoo, Kelkoo) and deep HealthTech, giving him a rare ability to translate consumer engagement metrics into healthcare valuations.

He serves as a Health Executive in Residence at UCL Global Business School for Health, further cementing his academic and strategic influence.

Paul Hemings

Hemings brings extensive corporate finance experience, including $50+ billion in M&A and equity transactions across global markets.

His background includes co-founding Neutrally, a venture focusing on chronic lifestyle disease, which complements the firm's focus on metabolic health and longevity. His expertise is pivotal in structuring complex deals involving cross-border entities.